» Articles » PMID: 38765253

Acute Upper and Lower Gastrointestinal Bleeding Management in Older People Taking or Not Taking Anticoagulants: a Literature Review

Overview
Specialty General Medicine
Date 2024 May 20
PMID 38765253
Authors
Affiliations
Soon will be listed here.
Abstract

Acute upper and lower gastrointestinal (GI) bleeding may be a potentially life-threatening event that requires prompt recognition and an early effective management, being responsible for a considerable number of hospital admissions. Methods. We perform a clinical review to summarize the recent international guidelines, helping the physician in clinical practice. Older people are a vulnerable subgroup of patients more prone to developing GI bleeding because of several comorbidities and polypharmacy, especially related to an increased use of antiplatelet and anticoagulant drugs. In addition, older patients may have higher peri-procedural risk that should be evaluated. The recent introduction of reversal strategies may help the management of GI bleeding in this subgroup of patients. In this review, we aimed to (1) summarize the epidemiology and risk factors for upper and lower GI bleeding, (2) describe treatment options with a focus on pharmacodynamics and pharmacokinetics of different proton pump inhibitors, and (3) provide an overview of the clinical management with flowcharts for risk stratification and treatment. In conclusion, GI is common in older patients and an early effective management may be helpful in the reduction of several complications.

Citing Articles

Management of gastrointestinal bleed in the intensive care setting, an updated literature review.

Nagesh V, Pulipaka S, Bhuju R, Martinez E, Badam S, Nageswaran G World J Crit Care Med. 2025; 14(1):101639.

PMID: 40060732 PMC: 11671843. DOI: 10.5492/wjccm.v14.i1.101639.


[Potential Impact of Community Pharmacist Interventions in Patients Treated with Coumarin Anticoagulants].

Saez-Benito A, Saez-Benito L, Salazar M, Berenguer N Aten Primaria. 2025; 57(7):103217.

PMID: 39874676 PMC: 11810692. DOI: 10.1016/j.aprim.2025.103217.

References
1.
Lin C, Cheng H, Kuo C, Lee Y, Sung C, Keidan M . Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection. Microbiol Spectr. 2022; 10(4):e0048622. PMC: 9430933. DOI: 10.1128/spectrum.00486-22. View

2.
Trifan A, Stanciu C, Girleanu I, Stoica O, Singeap A, Maxim R . Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. World J Gastroenterol. 2017; 23(35):6500-6515. PMC: 5643276. DOI: 10.3748/wjg.v23.i35.6500. View

3.
Sung J, Chiu P, Chan F, Lau J, Goh K, Ho L . Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018. Gut. 2018; 67(10):1757-1768. PMC: 6145289. DOI: 10.1136/gutjnl-2018-316276. View

4.
Srygley F, Gerardo C, Tran T, Fisher D . Does this patient have a severe upper gastrointestinal bleed?. JAMA. 2012; 307(10):1072-9. DOI: 10.1001/jama.2012.253. View

5.
Oakland K, Chadwick G, East J, Guy R, Humphries A, Jairath V . Diagnosis and management of acute lower gastrointestinal bleeding: guidelines from the British Society of Gastroenterology. Gut. 2019; 68(5):776-789. DOI: 10.1136/gutjnl-2018-317807. View